Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Platform: GPL24247 | Expression profiling by high throughput sequencing | Jun 26, 2024 | |||||
GSE269300 |
PI3Kg in B cells promotes antibody responses and generation of antibody-secreting cells [scRNA-seq]
|
|
6 | Anis Barmada | Jun 26, 2024 | |||
GSE269303 |
PI3Kg in B cells promotes antibody responses and generation of antibody-secreting cells [RNA-seq]
|
|
19 | Anis Barmada | Jun 26, 2024 | |||
GSE260908 |
Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant
|
|
6 | Dafei Chai | Jun 26, 2024 | |||
GSE249304 |
IL-13 decreases suceptibility to airway epithelial SARS-CoV-2 infection but increases disease severity in vivo [Bulk RNA-seq]
|
|
16 | Alejandro Pezzulo Colmenares | Jun 26, 2024 | |||
GSE254999 |
Loss of Inpp5d has disease-relevant and sex-specific effects on glial transcriptomes
|
|
12 | Luke Child Dabin | Jun 26, 2024 | |||
GSE254428 |
Transcriptional remodeling by OTX2 directs specification and patterning of mammalian definitive endoderm [scRNA-seq]
|
|
2 | Ly-sha Ee | Jun 26, 2024 | |||
GSE254402 |
Effect of human recombinent Annexin A5 on gene expression of bone marrow derived macrophages polarizaionn with LPS and IFN-gama
|
|
9 | Zhuoxuan Jia | Jun 26, 2024 | |||
GSE240980 |
Cellular fitness of MYC-driven cancer cells to genetic and pharmacologic perturbations in normoxia, hypoxia and 3D
|
|
8 | Hongjian Jin | Jun 26, 2024 | |||
GSE263577 |
Fecal microbiota transfer from autoimmune dry eye disease model mice to conventional mice induces ocular surface inflammation and stereotypic B cell receptor repertoire development in lacrimal gland
|
|
48 | Soobin Lee | Jun 26, 2024 | |||
GSE262687 |
Integrin αM promotes macrophage alternative M2 polarization in hyperuricemia-related chronic kidney disease
|
|
6 | Jing Liu | Jun 26, 2024 | |||
GSE270447 |
Targeting fatty acid metabolism to abrogate differentiation block in pre-leukemia induced by AML1-ETO
|
|
14 | Yu Liu | Jun 26, 2024 | |||
GSE261137 |
Cancer EVP Uptake in Lung Interstitial Macrophages Enhances Vascular Permeability and Metastatic Potential (in vitro)
|
|
10 | David Lyden | Jun 26, 2024 | |||
GSE261138 |
Cancer EVP Uptake in Lung Interstitial Macrophages Enhances Vascular Permeability and Metastatic Potential (in vivo)
|
|
6 | David Lyden | Jun 26, 2024 | |||
GSE261139 |
Tumour-derived Extracellular Vesicle and Particle Reprogramming of Interstitial Macrophages in the Lung Pre-Metastatic Niche Enhances Vascular Permeability and Metastatic Potential
|
|
16 | David Lyden | Jun 26, 2024 | |||
GSE235987 |
Enhancer-AAVs allow genetic access to diverse populations of astrocytes and oligodendrocytes across species
|
|
2040 | John Kenneth Mich | Jun 26, 2024 | |||
GSE269182 |
CCR1 drives immunosuppressive properties of tumor associated macrophages in pancreatic cancer
|
|
2 | Marina Pasca di Magliano | Jun 26, 2024 | |||
GSE269888 |
Oncogenic KRAS-dependent stromal interleukin-33 directs the pancreatic microenvironment to promote tumor growth [scRNA-seq]
|
|
11 | Marina Pasca di Magliano | Jun 26, 2024 | |||
GSE269889 |
Oncogenic KRAS-dependent stromal interleukin-33 directs the pancreatic microenvironment to promote tumor growth [bulk RNA-seq]
|
|
16 | Marina Pasca di Magliano | Jun 26, 2024 | |||
GSE246051 |
Iron chelation therapy elicits innate immune control of metastatic ovarian cancer
|
|
9 | Tito Alejandro A Sandoval Medina | Jun 26, 2024 | |||
GSE261698 |
A glial circadian gene expression atlas reveals cell type and disease-specific reprogramming in response to amyloid pathology or aging
|
|
165 | Patrick Sheehan | Jun 26, 2024 |